87 related articles for article (PubMed ID: 15899625)
1. [Cardiovascular toxicity of some cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].
Saintigny P; Chouahnia K; Charniot JC; Breau JL
Bull Cancer; 2004 Nov; 91 Suppl 3():174-84. PubMed ID: 15899625
[TBL] [Abstract][Full Text] [Related]
2. [Cardiotoxicity of drugs used in oncology].
Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
[TBL] [Abstract][Full Text] [Related]
3. Anticancer agents and cardiotoxicity.
Ng R; Better N; Green MD
Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Jensen BV
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular complications in oncology patients].
Suzuki Y; Tokuda Y
Nihon Rinsho; 2003 Jun; 61(6):984-9. PubMed ID: 12806947
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity of systemic agents used in breast cancer.
Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of cardiotoxicity induced by anthracyclines.
Elliott P
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of systemic cancer treatment.
Senkus E; Jassem J
Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy and cardiotoxicity].
Brestescher C; Pautier P; Farge D
Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):443-7. PubMed ID: 8669796
[TBL] [Abstract][Full Text] [Related]
10. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.
Jones RL; Ewer MS
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1249-69. PubMed ID: 17020459
[TBL] [Abstract][Full Text] [Related]
11. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.
Du XL; Xia R; Liu CC; Cormier JN; Xing Y; Hardy D; Chan W; Burau K
Cancer; 2009 Nov; 115(22):5296-308. PubMed ID: 19672997
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular toxicity associated with cancer treatment.
Viale PH; Yamamoto DS
Clin J Oncol Nurs; 2008 Aug; 12(4):627-38. PubMed ID: 18676329
[TBL] [Abstract][Full Text] [Related]
13. Cardiac side-effects of cancer chemotherapy.
Monsuez JJ; Charniot JC; Vignat N; Artigou JY
Int J Cardiol; 2010 Sep; 144(1):3-15. PubMed ID: 20399520
[TBL] [Abstract][Full Text] [Related]
14. [Towards an integrated approach to cardiovascular toxicities related to the treatments of breast cancer].
Tanz R; Magne N; Annede P; Mery B; Jacob J; Bauduceau O; Trone JC; Guichard JB; Meillan N; Kirova Y; Vedrine L; Chargari C
Bull Cancer; 2014; 101(7-8):730-40. PubMed ID: 25091656
[TBL] [Abstract][Full Text] [Related]
15. [The cardiac toxicity of cancer chemotherapy].
Sequeira JF; Madruga IM; Ribeiro M; Duarte PC; Ferreira DC; Sarmento JL
Acta Med Port; 1994 May; 7(5):311-8. PubMed ID: 8073908
[TBL] [Abstract][Full Text] [Related]
16. [Cardiac disease in patients with tumors and tumor therapy].
Hoppe UC
Med Klin (Munich); 2006 Mar; 101 Suppl 1():31-5. PubMed ID: 16802515
[TBL] [Abstract][Full Text] [Related]
17. Prevention and management of cardiotoxicity from antineoplastic therapy.
Chanan-Khan A; Srinivasan S; Czuczman MS
J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced cardiovascular toxicity: beyond anthracyclines.
Ai D; Banchs J; Owusu-Agyemang P; Cata JP
Minerva Anestesiol; 2014 May; 80(5):586-94. PubMed ID: 24122036
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating anthracycline cardiotoxicity in children with cancer: clinical trials with dexrazoxane.
Wexler LH
Semin Oncol; 1998 Aug; 25(4 Suppl 10):86-92. PubMed ID: 9768829
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity of cancer therapy.
Floyd JD; Nguyen DT; Lobins RL; Bashir Q; Doll DC; Perry MC
J Clin Oncol; 2005 Oct; 23(30):7685-96. PubMed ID: 16234530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
